Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty

Martijn Akkerhuis; MJBM (Marcel) van den Brand; C Zwaan; HOJ Peels; H (Harry) Suryapranata; LR van der Wieken; J (Jeanne) Stibbe; J Hoffmann; T Baardman; Jaap Deckers; Maarten Simoons

Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty

Martijn Akkerhuis, MJBM (Marcel) van den Brand, C Zwaan, HOJ Peels, H (Harry) Suryapranata, LR van der Wieken, J (Jeanne) Stibbe, J Hoffmann, T Baardman, Jaap Deckers, Maarten Simoons

Research output: Contribution to journal › Article › Academic › peer-review

9 Citations (Scopus)

16 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	444-450
Number of pages	7
Journal	Heart
Volume	85
Publication status	Published - 2001

Research programs

EMC 05-01-43-06-03

Access to Document

11250974.pdfFinal published version, 267 KB

http://hdl.handle.net/1765/8332

Cite this

Akkerhuis, M., van den Brand, MJBM., Zwaan, C., Peels, HOJ., Suryapranata, H., van der Wieken, LR., Stibbe, J., Hoffmann, J., Baardman, T., Deckers, J., & Simoons, M. (2001). Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty. Heart, 85, 444-450. http://hdl.handle.net/1765/8332

@article{773e581d3dae4fc3be6193a21a5da454,

title = "Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty",

author = "Martijn Akkerhuis and \{van den Brand\}, \{MJBM (Marcel)\} and C Zwaan and HOJ Peels and Suryapranata, \{H (Harry)\} and \{van der Wieken\}, LR and Stibbe, \{J (Jeanne)\} and J Hoffmann and T Baardman and Jaap Deckers and Maarten Simoons",

year = "2001",

language = "Undefined/Unknown",

volume = "85",

pages = "444--450",

journal = "Heart",

issn = "1355-6037",

publisher = "BMJ Publishing Group",

}

Akkerhuis, M, van den Brand, MJBM, Zwaan, C, Peels, HOJ, Suryapranata, H, van der Wieken, LR, Stibbe, J, Hoffmann, J, Baardman, T, Deckers, J & Simoons, M 2001, 'Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty', Heart, vol. 85, pp. 444-450. <http://hdl.handle.net/1765/8332>

Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty. / Akkerhuis, Martijn; van den Brand, MJBM (Marcel); Zwaan, C et al.
In: Heart, Vol. 85, 2001, p. 444-450.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty

AU - Akkerhuis, Martijn

AU - van den Brand, MJBM (Marcel)

AU - Zwaan, C

AU - Peels, HOJ

AU - Suryapranata, H (Harry)

AU - van der Wieken, LR

AU - Stibbe, J (Jeanne)

AU - Hoffmann, J

AU - Baardman, T

AU - Deckers, Jaap

AU - Simoons, Maarten

PY - 2001

Y1 - 2001

M3 - Article

SN - 1355-6037

VL - 85

SP - 444

EP - 450

JO - Heart

JF - Heart

ER -